Резюме
Определение
Анамнез и осмотр
Ключевые диагностические факторы
- presença de fatores de risco
- febre, calafrios, mal-estar
- próstata com sensibilidade à palpação
Другие диагностические факторы
- idade <50 anos
- polaciúria
- disúria
- diminuição do fluxo urinário
- dor perineal
- glândula esponjosa, quente ou amolecida
- sonda vesical de demora
- biópsia prostática transretal recente
- cirurgia transuretral recente
Факторы риска
- infecção do trato urinário (ITU)
- aumento prostático benigno
- instrumentação/manipulação do trato urinário
- saúde geral ruim/imunossupressão
- tabagismo e consumo de bebidas alcoólicas
- genética
Диагностические исследования
Исследования, которые показаны в первую очередь
- urinálise
- urocultura
- hemoculturas
Исследования, проведение которых нужно рассмотреть
- ultrassonografia transretal
- teste de 2 frascos ou 4 frascos
Неотложные исследования
- citologia da urina
- cistoscopia
- biópsia de próstata
Алгоритм лечения
sinais de sepse
sem sinais de sepse
Составители
Авторы
Christopher Chapple, BSc, MD, FRCS (Urol), FEBU
Honorary Senior Lecturer of Urology
University of Sheffield
Consultant Urological Surgeon
Department of Urology
Royal Hallamshire Hospital
Sheffield
UK
Раскрытие информации
CC is a consultant for Astellas, Contura, Ferring, Symimetic, Takeda, and Urovant Sciences. He is an author for Astellas and Ferring. He is an investigator for Allergan, Astellas, Ferring, Poesis Medical, and Bayer. He is a co-patent holder for Symimetic. He is a speaker for Allergan and Astellas.
Altaf Mangera, MBChB (Hons), MD, FRCS (Urol)
Consultant Urologist
Department of Urology
Royal Hallamshire Hospital
Sheffield
UK
Раскрытие информации
AM declares that he has no competing interests.
Выражение благодарностей
Dr Christopher Chapple and Dr Altaf Mangera would like to gratefully acknowledge the contribution of Robyn Webber MB, ChB, MD, FRCSEd (Urol) to this topic. Not disclosed.
Рецензенты
Hans Hedelin, MD
Department of Urology and Centre for Research and Development
Karnsjukhuset
Skovde
Sweden
Раскрытие информации
HH declares that he has no competing interests.
Benjamin A. Lipsky, MD, FACP, FIDSA, FRCP
Professor of Medicine
University of Washington
VA Puget Sound Health Care System
Seattle
WA
Раскрытие информации
BAL has received research funding from, and been a consultant to, several pharmaceutical companies that make antibiotic agents that might be used for treating bacterial prostatitis.
Peer reviewer acknowledgements
BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.
Disclosures
Peer reviewer affiliations and disclosures pertain to the time of the review.
Список литературы
Основные статьи
Rothman JR, Jaffe WI. Prostatitis: updates on diagnostic evaluation. Curr Urol Rep. 2007 Jul;8(4):301-6. Аннотация
Krieger JN, Lee SW, Jeon J, et al. Epidemiology of prostatitis. Int J Antimicrob Agents. 2008 Feb;31(suppl 1):S85-90.Полный текст Аннотация
European Association of Urology. Guidelines on urological infections. 2022 [internet publication].Полный текст
Nickel JC. Prostatitis. Can Urol Assoc J. 2011 Oct;5(5):306-15.Полный текст Аннотация
National Institute for Health and Care Excellence. Prostatitis (acute): antimicrobial prescribing. Oct 2018 [internet publication].Полный текст
Статьи, указанные как источники
A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
Отличия
- Hiperplasia prostática benigna (HPB)
- Câncer de próstata
- Infecção do trato urinário (ITU)
Больше ОтличияРекомендации
- Urological infections
- Prostatitis (acute): antimicrobial prescribing
Больше РекомендацииЛифлеты для пациента
Prostatite
Больше Лифлеты для пациента
Войдите в учетную запись или оформите подписку, чтобы получить полноценный доступ к BMJ Best Practice
Использование этого контента попадает под действие нашего заявления об отказе от ответственности